tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ENLV Stock Latest News

Enlivex Therapeutics to present clinical data of Allocetra in osteoarthritis
The FlyEnlivex Therapeutics to present clinical data of Allocetra in osteoarthritis
2M ago
ENLV
Enlivex Reports Q1 2025 Financial Results with Reduced Loss
PremiumCompany Announcements
Enlivex Reports Q1 2025 Financial Results with Reduced Loss
2M ago
6K
ENLV
Enlivex Therapeutics selected to present at Israeli BioMed 2025 conference
PremiumThe Fly
Enlivex Therapeutics selected to present at Israeli BioMed 2025 conference
2M ago
ENLV
Enlivex Therapeutics files $300M mixed securities shelf
PremiumThe Fly
Enlivex Therapeutics files $300M mixed securities shelf
3M ago
ENLV
Enlivex’s Promising Clinical Progress and Strategic Collaborations Justify Buy Rating
PremiumRatings
Enlivex’s Promising Clinical Progress and Strategic Collaborations Justify Buy Rating
3M ago
ENLV
Enlivex to Present Allocetra™ Insights at OARSI 2025
PremiumCompany AnnouncementsEnlivex to Present Allocetra™ Insights at OARSI 2025
3M ago
6K
ENLV
Enlivex Completes Phase II Enrollment for Osteoarthritis Trial
Premium
Company Announcements
Enlivex Completes Phase II Enrollment for Osteoarthritis Trial
3M ago
6K
ENLV
Enlivex completed enrollment of patients in Phase II trial of Allocetra
Premium
The Fly
Enlivex completed enrollment of patients in Phase II trial of Allocetra
3M ago
ENLV
Enlivex Begins Phase I Trial for TMJ Osteoarthritis Treatment
PremiumCompany Announcements
Enlivex Begins Phase I Trial for TMJ Osteoarthritis Treatment
4M ago
6K
ENLV
Enlivex Therapeutics doses first patient in Phase I trial of Allocetra
PremiumThe Fly
Enlivex Therapeutics doses first patient in Phase I trial of Allocetra
4M ago
ENLV
Enlivex Therapeutics Releases 2024 Financial Statements
PremiumCompany Announcements
Enlivex Therapeutics Releases 2024 Financial Statements
4M ago
6K
ENLV
Enlivex Therapeutics price target raised to $7 from $6 at H.C. Wainwright
PremiumThe Fly
Enlivex Therapeutics price target raised to $7 from $6 at H.C. Wainwright
4M ago
ENLV
Enlivex Secures Chinese Patent Allowance for Osteoarthritis Treatment
PremiumCompany AnnouncementsEnlivex Secures Chinese Patent Allowance for Osteoarthritis Treatment
4M ago
6K
ENLV
Enlivex Therapeutics receives notice of allowance for Chinese patent
Premium
The Fly
Enlivex Therapeutics receives notice of allowance for Chinese patent
4M ago
ENLV
Enlivex Reports Promising Interim Results in Osteoarthritis Trial
Premium
Company Announcements
Enlivex Reports Promising Interim Results in Osteoarthritis Trial
5M ago
6K
ENLV
Enlivex Reports Promising Interim Results in Knee Osteoarthritis Trial
PremiumCompany Announcements
Enlivex Reports Promising Interim Results in Knee Osteoarthritis Trial
5M ago
6K
ENLV
Enlivex announces interim 6-month efficacy data from Phase I of Allocetra trial
PremiumThe Fly
Enlivex announces interim 6-month efficacy data from Phase I of Allocetra trial
5M ago
ENLV
Enlivex Therapeutics Completes Initial Dosing in Phase I Psoriatic Arthritis Trial
PremiumMarket News
Enlivex Therapeutics Completes Initial Dosing in Phase I Psoriatic Arthritis Trial
5M ago
ENLV
Israel’s Health Ministry Backs Enlivex Therapeutics (NASDAQ:ENLV) for Sheba Medical Center Trials
PremiumMarket News
Israel’s Health Ministry Backs Enlivex Therapeutics (NASDAQ:ENLV) for Sheba Medical Center Trials
5M ago
ENLV
Enlivex Therapeutics Starts Phase II Allocetra Trail to Treat Knee Osteoarthritis
PremiumMarket NewsEnlivex Therapeutics Starts Phase II Allocetra Trail to Treat Knee Osteoarthritis
5M ago
ENLV
Enlivex Wins Key Patent in Japan for Osteoarthritis Treatment
Premium
Market News
Enlivex Wins Key Patent in Japan for Osteoarthritis Treatment
5M ago
ENLV
Enlivex Therapeutics (NASDAQ:ENLV) Hails Positive Trial Results for Allocetra Treatment of Knee Osteoarthritis
Premium
Market News
Enlivex Therapeutics (NASDAQ:ENLV) Hails Positive Trial Results for Allocetra Treatment of Knee Osteoarthritis
5M ago
ENLV

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >